2025 Partners
AMRA Medical
Expertise Partner
AMRA Medical is a health informatics and precision medicine company that is pioneering body composition analysis, providing cutting-edge solutions to advance both clinical research and patient care initiatives. AMRA's gold-standard technology delivers multiple fat and muscle biomarkers - derived simply from rapid whole-body MRI scans. AMRA is committed to driving transformative care and simplifying vital decision-making in both research and clinical settings by offering support services via their innovative platform to help advance disease research in obesity and beyond.
Antaros Medical
Expertise Partner
Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and deliver clinical imaging studies. Applied with our extensive experience and expertise in drug development and disease biology, our tailored solutions have helped our customers to solve complex problems to empower confident decision-making at every stage of clinical drug development, from small mechanistic studies to large scale studies. Disease areas: CV, renal & metabolic diseases and oncology.
The Jackson Laboratory
Expertise Partner
JAX® Mice, Clinical and Research Services (JMCRS) has been supporting public access to models and technologies developed at The Jackson Laboratory for over 20 years. JAX Preclinical Services delivers advanced solutions for metabolic research, offering a full range of in vivo metabolic and phenotyping services designed to support preclinical drug discovery and translational studies. Our validated mouse models facilitate the investigation of disease pathology, metabolic dysfunction, and therapeutic strategies, serving as a powerful platform for drug discovery and target validation. Leveraging advanced phenotyping capabilities and scientific expertise, JMCRS empowers researchers to drive metabolic research forward and expedite the development of innovative treatments for diabetes and obesity.
Perspectum
Expertise Partner
Perspectum is an innovative company pushing the frontier of personalized medicine through our advanced non-invasive imaging portfolio. Working across the obesity and metabolic disease space, our best-in-class precision health technology provides sponsors with tangible insights into the mechanisms and benefits of their incretin-based treatments. Working across the entire development pipeline, we support sponsors to differentiate their treatments by allowing them to see and quantify more than ever before.
NBCD
Expertise Partner
NBCD (Nordic Bioscience Clinical Development) is a global full-service CRO specialized in musculoskeletal disorders and obesity. NBCD was established in 2006 and offers scientific and clinical trial services within musculoskeletal disorders and obesity to the biotech and pharmaceutical industry.
A positive cash flow allows us to invest in-kind support and share the risk and thus the incentive for drug development with our partners.
As a science-driven organization, we engage in all phases of drug development; scientifically, operationally, and financially. Each year, we publish several articles in well-respected peer-reviewed journals.
Worldwide Clinical Trials
Expertise Partner
Worldwide Clinical Trials (Worldwide) is a leading global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications, from discovery to reality. Our full-service clinical development capabilities include bioanalytical laboratory services and Phase I-IV clinical trials, as well as post-approval and real-world evidence studies – all powered by our talented and accessible team of clinicians, scientists, and researchers who bring their first-hand expertise to each clinical program.
At Worldwide, we understand that each customer and project are unique, so we take a collaborative and personalized approach to identify and meet specific needs and goals. Anchored in our company’s scientific heritage, we are therapeutically focused on cardiovascular, metabolic, neuroscience, oncology, and rare diseases. We apply this deep therapeutic knowledge to develop flexible plans and quickly solve problems in the rapidly evolving clinical development landscape.
Our team of 3,000+ professionals spans 60+ countries, and believes that through collaboration, and a culture that embraces diversity, equity, inclusion, and belonging (DEI&B), everyone plays an important role in making a world of difference for patients and their caregivers. We are united in cause with our customers to improve the lives of patients through new, innovative therapies.
Waters Corporation
Expertise Partner
At Waters, we unlock the potential of science by solving problems that matter. Our software and instruments ensure the safety of the medicines we take, the purity of the food we eat and the water we drink, and the quality and durability of products we use every day. Together with our customers, in labs around the world, we deliver scientific insights to improve human health and well-being, helping to leave the world better than we found it.
ICON
Hosting Partner
ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,900 employees in 106 locations in 55 countries as at December 31, 2024.
National Academy of Sports Medicine
Hosting Partner
The National Academy of Sports Medicine (NASM) is an organization that provides certification, education, and career development opportunities for professionals in the fitness, wellness, and sports industries. NASM has gained recognition for its evidence-based approach to fitness and wellness education and has developed a range of programs aimed at enhancing the skills of personal trainers, wellness coaches, athletic trainers, strength and conditioning coaches, physical therapists, and other health professionals.
Clinical Ink
Innovation Partner
Clinical ink is the global life science company bringing data, technology, and patient-centric research together. Our deep therapeutic-area expertise, coupled with behavioral science, eDC/Direct Data Capture, eCOA, eConsent, telehealth, and digital biomarkers advancement (including the use of Continuous Glucose Monitoring for detection of hypoglycemia), support the next generation of clinical trials and ultimately, the clinical management of patients.
Promega
Innovation Partner
Promega provides innovative bioassays and analytical tools to accelerate obesity drug discovery. Our portfolio includes functional GPCR assays for GLP-1, GIP, and glucagon receptors, luminescent assays for insulin and energy metabolism, and cytokine profiling solutions for inflammation research. Whether optimizing receptor signaling, studying metabolic pathways, or developing custom bioassays, Promega delivers scalable, high-quality solutions to advance obesity therapeutics.
Verified Clinical Trials
Innovation Partner
"Professional" & duplicate research participants have been doing the clinical research industry a disservice for far too long.
GLP-1 studies pose a unique risk due to the size of trials, number of competing trials looking for the same participant profile with similar inclusion/exclusion criteria, and new sponsors entering the space.
Verified Clinical Trials can prevent (vs detect) cross-sponsor, cross-therapeutic area, and cross-phase dual enrollment, at screening, in an effort to enhance patient safety, data quality, study integrity, and will ultimately save time & money as dually enrolled participants will not need to be dropped and re-recruited.
At screening, VCT determines participant eligibility by comparing the protocol's inclusion and exclusion criteria to the research participant's current and past research history. Without Verified Clinical Trials, this is a gap in the screening process.
Let's collaborate to ensure clinical trials are enrolling the most qualified participants possible!
uMED
Innovation Partner
uMed enables life sciences to rapidly access real-world insights through our SnapACCESS platform —our turnkey solution for fast, scalable evidence generation. This includes over 5,000 IRB-consented patients with obesity and diabetes (which is rapidly increasing), with EMR- and PRO-linked data. The platform supports rapid delivery of custom qualitative insights, with study outputs available in under 4 weeks—ideal for supporting GLP-1 research and decision-making.
AnaSpec
Event Partner
AnaSpec is a U.S. manufacturer of Peptides and Peptidomimetics, with over 30 years of expertise in complex to simple peptides and peptide libraries. Globally recognized for quality and product excellence, we serve the biopharmaceutical industry, diagnostic companies, agro-food firms, academia, and governmental institutions. Our custom manufacturing capabilities cover every stage of the product lifecycle—from R&D through GMP-grade production for clinical applications. GLP-1 off-the-shelf research-use peptides are also available from our large catalog portfolio.
Cardiomedex
Event Partner
Cardiomedex is a preclinical CRO, highly specialized in cardiovascular and cardiometabolic diseases in collaboration with its affiliates company Physiogenex, specialized in metabolic diseases (obesity/type 2 diabetes & comorbidities). Cardiomedex provides reliable preclinical studies using integrative predictive models of HFpEF , HFrEF, cardiac hypertrophy & fibrosis, myocardial infarction, cardiomyopathy (takotsubo, genetic..), cardiometabolic diseases, hypertension, cardiotoxicity, etc. and new tailor-made models to fulfil our partners’ needs. Cardiomedex offers ex-vivo (vascular reactivity/isolated heart/cardiomyocytes/mitochondrial function) and in-vivo exploration (echocardiography/telemetry/PV loops/ECG/treadmill/tail cuff) to provide in-depth functional characterization.